This indicates that most ER(-)/PR(+) breast cancers have the molecular characteristics of triple negative breast cancer cases, which is also the reason why ER(-)/PR(+) has similar clinical features and prognosis to ER(-)/PR(-). The gene discussed is ESR1; the disease is breast carcinoma.